Sustained Improvement in Photodamaged Skin with Reduced Tretinoin Emollient Cream Treatment Regimen: Effect of Once-weekly and Three-times-weekly Applications
Overview
Authors
Affiliations
Background: Previous studies have documented reversal of long-term photodamage with once-daily applications of topical tretinoin.
Objective: Our purpose was to assess the effectiveness of tretinoin emollient cream in maintaining improvement in photodamage with a reduced frequency of applications.
Methods: A total of 126 subjects who completed 48 weeks of once-daily treatment with tretinoin emollient cream 0.05% were enrolled for an additional 24 weeks of tretinoin once weekly, three times weekly, or no therapy.
Results: The clinical improvement observed during 48 weeks of once-daily treatment was sustained with three-times weekly applications and to a lesser extent with once-weekly dosing, whereas effects tended to regress in subjects off therapy. The overall incidence of adverse events in the skin and subcutaneous tissues appeared to vary with dose frequency.
Conclusion: After 48 weeks of once-daily treatment, the continued use of tretinoin emollient cream 0.05% at a dose of three times per week maintains and, in some cases, may further enhance improvement in photodamage. Discontinuation of therapy results in some reversal of beneficial effects.
Chunekamrai P, Chatpimolkul N, Thummawatwimon S, Treesirichod A Arch Dermatol Res. 2025; 317(1):297.
PMID: 39833642 DOI: 10.1007/s00403-025-03821-y.
Perez Davo A, Truchuelo M, Vitale M, Gonzalez-Castro J J Clin Aesthet Dermatol. 2019; 12(7):E65-E70.
PMID: 31531164 PMC: 6715328.
Retinoids: Literature Review and Suggested Algorithm for Use Prior to Facial Resurfacing Procedures.
Buchanan P, Gilman R J Cutan Aesthet Surg. 2016; 9(3):139-144.
PMID: 27761082 PMC: 5064676. DOI: 10.4103/0974-2077.191653.
McKenzie N, Saboda K, Duckett L, Goldman R, Hu C, Curiel-Lewandrowski C Arch Dermatol. 2011; 147(1):31-6.
PMID: 21242389 PMC: 4133014. DOI: 10.1001/archdermatol.2010.392.
Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.
Mukherjee S, Date A, Patravale V, Korting H, Roeder A, Weindl G Clin Interv Aging. 2007; 1(4):327-48.
PMID: 18046911 PMC: 2699641. DOI: 10.2147/ciia.2006.1.4.327.